Christiansburg, VA, United States of America

Ariel Louise Burgio

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: University of Virginia Patent Foundation, Virginia Tech Intellectual Properties Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ariel Louise Burgio. Retrieved from https://idiyas.com/inventor/ariel-louise-burgio

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ariel Louise Burgio

Introduction

Ariel Louise Burgio is an inventor associated with Christiansburg, Virginia. His patent work includes research into SPNS2 inhibitors and their potential therapeutic applications.

Latest Patents

Burgio is named on one patent, 1 patent: “Inhibitors of Spinster Homolog 2 (SPNS2) for Use in Therapy.” The disclosure describes SPNS2 inhibitor compounds, their pharmaceutically acceptable salts and tautomers, pharmaceutical compositions, and methods for therapeutic use.

Career Highlights

Burgio is associated with the University of Virginia Patent Foundation and Virginia Tech Intellectual Properties Inc. These organizations are connected with the development and management of intellectual property arising from research and innovation.

Collaborations

His listed collaborators include Kevin R. Lynch and Yugesh Kharel. Their shared work is reflected in the patent disclosure on SPNS2 inhibitors.

Conclusion

Ariel Louise Burgio’s patent activity highlights collaborative research into SPNS2 inhibitors and their potential use in therapy.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…